coumarin has been researched along with Colorectal Cancer in 3 studies
2H-chromen-2-one: coumarin derivative
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hersi, F | 1 |
Omar, HA | 1 |
Al-Qawasmeh, RA | 1 |
Ahmad, Z | 1 |
Jaber, AM | 1 |
Zaher, DM | 1 |
Al-Tel, TH | 1 |
Carney, IJ | 1 |
Kolanowski, JL | 1 |
Lim, Z | 1 |
Chekroun, B | 1 |
Torrisi, AG | 1 |
Hambley, TW | 1 |
New, EJ | 1 |
Draoui, N | 1 |
Schicke, O | 1 |
Seront, E | 1 |
Bouzin, C | 1 |
Sonveaux, P | 1 |
Riant, O | 1 |
Feron, O | 1 |
3 other studies available for coumarin and Colorectal Cancer
Article | Year |
---|---|
Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Proliferation; Cisplatin; Colorectal Neoplasms; | 2020 |
A ratiometric iron probe enables investigation of iron distribution within tumour spheroids.
Topics: Colorectal Neoplasms; Coumarins; Fluoresceins; Fluorescent Dyes; Humans; Iron; Iron Chelating Agents | 2018 |
Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux.
Topics: Animals; Breast Neoplasms; Colorectal Neoplasms; Coumarins; Female; HCT116 Cells; Humans; Lactic Aci | 2014 |